Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
暂无分享,去创建一个
Scott L. Pomeroy | Paul A. Northcott | Andrey Korshunov | Marco Marra | Eric Bouffet | Cynthia Hawkins | Marcel Kool | M. Marra | M. Kool | P. Northcott | S. Pfister | J. Rutka | C. Hawkins | S. Pomeroy | Yoon-Jae Cho | A. Korshunov | M. Remke | Michael D. Taylor | D. Malkin | C. Eberhart | A. Dubuc | D. Shih | E. Bouffet | T. Guettouche | Marc Remke | Yoon-Jae Cho | Stefan Pfister | James T. Rutka | David Malkin | Charles G. Eberhart | Yoslayma Cardentey | Toumy Guettouche | Adrian Dubuc | David J. H. Shih | Yoslayma Cardentey
[1] Arie Perry,et al. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups , 2011, Acta Neuropathologica.
[2] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] Dirk Troost,et al. Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features , 2008, PloS one.
[4] Paul A. Northcott,et al. Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct , 2011, Acta Neuropathologica.
[5] F. D. de Sauvage,et al. Clinical experience with Hedgehog pathway inhibitors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] T. Merchant,et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. , 2006, The Lancet. Oncology.
[7] Hendrik Witt,et al. Medulloblastoma comprises four distinct molecular variants. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Jennifer L. Osborn,et al. Direct multiplexed measurement of gene expression with color-coded probe pairs , 2008, Nature Biotechnology.
[9] Paul A. Northcott,et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma , 2009, Nature Genetics.
[10] D. Ellison,et al. Rapid Diagnosis of Medulloblastoma Molecular Subgroups , 2011, Clinical Cancer Research.
[11] D. Ellison,et al. Wnt/Wingless Pathway Activation and Chromosome 6 Loss Characterise a Distinct Molecular Sub-Group of Medulloblastomas Associated with a Favourable Prognosis , 2006, Cell cycle.
[12] Richard Grundy,et al. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. , 2009, Cancer research.
[13] T. Curran,et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Meghana Kulkarni. Digital multiplexed gene expression analysis using the NanoString nCounter system. , 2011, Current protocols in molecular biology.
[15] J. Mesirov,et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] L. Waldron,et al. mRNA transcript quantification in archival samples using multiplexed, color-coded probes , 2011, BMC biotechnology.
[17] Axel Benner,et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Afshin Mashadi-Hossein,et al. Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter™ Assay System , 2009, BMC Research Notes.